FLT3 and leukemia: In conclusion, this study demonstrates that combined treatment with a FLT3 TKI and BCL-2i synergistically inhibits proliferation and induces apoptosis/cell death of FLT3/ITD leukemia cell lines and primary FLT3/ITD AML patient samples, both in vitro and in vivo.